New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury

J Wang, S Toan, H Zhou - Angiogenesis, 2020 - Springer
As reperfusion therapies have become more widely used in acute myocardial infarction
patients, ischemia-induced myocardial damage has been markedly reduced, but reperfusion …

Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies

M Liu, BL de Juan Abad, K Cheng - Advanced drug delivery reviews, 2021 - Elsevier
Cardiac fibrosis remains an unresolved problem in heart diseases. After initial injury, cardiac
fibroblasts (CFs) are activated and subsequently differentiate into myofibroblasts (myoFbs) …

Mitochondrial dysfunction in fibrotic diseases

X Li, W Zhang, Q Cao, Z Wang, M Zhao, L Xu… - Cell death …, 2020 - nature.com
Although fibrosis is a common pathological feature of most end-stage organ diseases, its
pathogenesis remains unclear. There is growing evidence that mitochondrial dysfunction …

Mitochondrial heterogeneity in diseases

L Chen, M Zhou, H Li, D Liu, P Liao, Y Zong… - … and Targeted Therapy, 2023 - nature.com
As key organelles involved in cellular metabolism, mitochondria frequently undergo
adaptive changes in morphology, components and functions in response to various …

SIRT1 prevents cigarette smoking-induced lung fibroblasts activation by regulating mitochondrial oxidative stress and lipid metabolism

Y Zhang, T Li, M Pan, W Wang, W Huang… - Journal of Translational …, 2022 - Springer
Background Cigarette smoking (CS) is a strong risk factor for idiopathic pulmonary fibrosis
(IPF). It can activate lung fibroblasts (LF) by inducing redox imbalance. We previously …

Oxidative stress in cardiac hypertrophy: From molecular mechanisms to novel therapeutic targets

CJA Ramachandra, S Cong, X Chan, EP Yap… - Free Radical Biology …, 2021 - Elsevier
When faced with increased workload the heart undergoes remodelling, where it increases
its muscle mass in an attempt to preserve normal function. This is referred to as cardiac …

Mitochondria‐targeted antioxidants: a step towards disease treatment

Q Jiang, J Yin, J Chen, X Ma, M Wu… - Oxidative medicine …, 2020 - Wiley Online Library
Mitochondria are the main organelles that produce adenosine 5′‐triphosphate (ATP) and
reactive oxygen species (ROS) in eukaryotic cells and meanwhile susceptible to oxidative …

TGF Beta− 1,− 2 and− 3 in the Modulation of Fibrosis in the Cornea and Other Organs

SE Wilson - Experimental eye research, 2021 - Elsevier
Abstract The TGF beta-1,-2 and-3 isoforms are transcribed from different genes but bind to
the same receptors and signal through the same canonical and non-canonical signal …

NRF2 in cardiovascular diseases: a ray of hope!

R Vashi, BM Patel - Journal of cardiovascular translational research, 2021 - Springer
Heart failure is a worldwide pandemic influencing 26 million individuals worldwide and is
expanding. Imbalanced redox homeostasis in cardiac cells alters the structure and function …

Mitochondrial dysfunction and mitochondrial therapies in heart failure

C Wu, Z Zhang, W Zhang, X Liu - Pharmacological Research, 2022 - Elsevier
Cardiovascular diseases remain the leading cause of death worldwide in the last decade,
accompanied by immense health and economic burdens. Heart failure (HF), as the terminal …